Results 201 to 210 of about 527,601 (286)
This study demonstrates a molecular strategy to enhance the stretchability of conjugated polymers by incorporating plasticizing molecular additives (PMAs). PMAs reduce the persistence length and promote chain entanglement, enabling deformable thin films with preserved electrical performance. A systematic analysis combining rheology, neutron scattering,
Sein Chung+11 more
wiley +1 more source
Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system. [PDF]
Song Q, Gao S, Tan Y.
europepmc +1 more source
Engineering Highly Cellularized Living Materials via Mechanical Agitation
A mechanical agitation strategy is developed to engineer highly cellularized living materials, achieving cell densities of up to 1 billion cells per milliliter. By precisely tuning properties such as stiffness and toughness in blood clots, the approach is validated in both in vitro and in vivo studies.
Aram Bahmani+9 more
wiley +1 more source
Adverse Event Costs and Cost-Effectiveness Analyses of Anticancer Drugs: A Systematic Review.
Zhao M+5 more
europepmc +1 more source
A real-world pharmacovigilance study of lorazepam based on the FDA adverse event reporting system database. [PDF]
Fang C+7 more
europepmc +1 more source
This paper presents a microphysiological system containing an array of individually addressable living corneal tissues constructed using primary human cells. The bioengineered eye model can simulate acute exposure of the human cornea to different types of environmental toxicants and provides a novel platform for visualization and quantitative ...
Se‐jeong Kim+12 more
wiley +1 more source
Incidence and outcome characteristics of adverse event in surgery: an assessment based on systematic reviews of barbed suture. [PDF]
Gu X+9 more
europepmc +1 more source
Adverse Events Associated with Autologous and Allogenic Blood Transfusion
Melanie S. Kennedy+5 more
openalex +1 more source
BX‐001N, a polyethylene glycol‐conjugated bilirubin 3α nanoparticle, is the first GMP‐grade, synthetic bilirubin‐based nanomedicine. It effectively attenuates acute renal injury, facilitates subacute renal recovery, and suppresses chronic fibrosis after renal ischemia/reperfusion injury via anti‐oxidant and immune‐modulating activity.
Ji‐Jing Yan+13 more
wiley +1 more source
Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system. [PDF]
Jiang J+6 more
europepmc +1 more source